Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
HLUNb | Copenhagen | DKK | Real-time | |
HLUNa | Copenhagen | DKK | Real-time | |
0ND5 | London | DKK | Real-time | |
LUNAM | Vienna | EUR | Real-time | |
LUNB | Vienna | EUR | Real-time |
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company’s principal products include Abilify Maintena/Abilify Maintena for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat MDD and schizophrenia. It also provides Azilect for treating Parkinson’s disease; Cipralex/Lexapro for depression; Ebixa to treat dementia; Onfi for epilepsy; Sabril for the treatment of refractory complex partial seizures and infantile spasms; Xenazine for chorea; Deanxit for depression; Cipramil for depression and anxiety; and Cisordinol to treat psychosis. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership collaboration with Otsuka Pharmaceuticals Co., Ltd.; and collaboration with Alloy Therapeutics, Inc. for the discovery of novel biologics therapies. The company was founded in 1915 and is headquartered in Valby, Denmark.
Name | Age | Since | Title |
---|---|---|---|
Lars Soren Rasmussen | 63 | 2013 | Independent Chairman |
Lars Erik Holmqvist | 63 | 2015 | Director |
Lene Skole-Sorensen | 63 | 2015 | Deputy Chairman |
Dorothea Wenzel | 53 | 2021 | Independent Director |
Hossein Armandi | 62 | 2022 | Employee Representative Director |
Santiago Arroyo | 64 | 2021 | Independent Director |
Jakob Riis | 58 | 2023 | Director |
Dorte Clausen | 40 | 2022 | Employee Representative Director |
Lasse Skibsbye | 41 | 2022 | Employee Representative Director |
Jeffrey Berkowitz | 58 | 2018 | Independent Director |
Camilla Gram Andersson | 52 | 2022 | Employee Representative Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review